Monitoring
Provide frequent follow-up during the first 2-4 months of therapy until remission occurs (acute phase). Monitor patients for adverse drug effects and response to therapy. Assess the degree of danger to self or others. It is important to monitor symptomatic and functional status of the individual, and to watch out for any switch to mania. Lastly, reassess therapy after 4-8 weeks.